Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology & Therapeutics, 28: 289-293.

In by AHF

Raltegravir: The First in a New Class of Integrase Inhibitors for the Treatment of HIV. Expert Review of Anti-Infective Therapy, 6(4): 419-426.
Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology and Therapeutics, 28: 289-293.
Download
File Type: pdf
File Size: 55 KB
Categories: 2008
Tags: 1999-2009